Greenwich Lifesciences Stock Target Price and Analyst Consensus

GLSI
 Stock
  

USD 8.53  0.62  6.78%   

The current analyst and expert consensus on Greenwich Lifesciences is Strong Buy, with 0 strong sell and 1 strong buy opinions. The current projected Greenwich Lifesciences target price consensus is 78.0 with 1 analyst opinions. The most common way Greenwich Lifesciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Greenwich Lifesciences executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Greenwich Lifesciences. We encourage you to use your own analysis of Greenwich Lifesciences to validate this buy or sell advice. Greenwich Lifesciences buy-or-sell recommendation module provides average expert sentiment on the projected Greenwich Lifesciences target price to derive its highest and lowest estimates based on projected price volatility of 0.0. Please check Macroaxis Advice on Greenwich Lifesciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
The current Consolidated Income is estimated to decrease to about (4.9 M). The current Earning Before Interest and Taxes EBIT is estimated to decrease to about (4.9 M)

Greenwich Lifesciences Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Greenwich target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Greenwich target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of OpinionsOne
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Greenwich analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Greenwich stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Greenwich Lifesciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Greenwich Lifesciences Target Price Projection

Greenwich Lifesciences' current and average target prices are 8.53 and 78.00, respectively. The current price of Greenwich Lifesciences is the price at which Greenwich Lifesciences is currently trading. On the other hand, Greenwich Lifesciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Greenwich Lifesciences Market Quote on 29th of June 2022

Low Price8.44Odds
High Price9.35Odds

8.53

Target Price

Analyst Consensus On Greenwich Lifesciences Target Price

Low Estimate78.0Odds
High Estimate78.0Odds
Number of AnalystsOne
Standard Deviation0.0

78.0

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Greenwich Lifesciences and the information provided on this page.

Greenwich Lifesciences Analyst Ratings

Greenwich Lifesciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Greenwich Lifesciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Greenwich Lifesciences' financials, market performance, and future outlook by experienced professionals. Greenwich Lifesciences' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Greenwich Lifesciences Target Price Projections

Greenwich Lifesciences's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Greenwich Lifesciences and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Greenwich depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Greenwich Lifesciences including its fundamental analysis.

Additional Greenwich Lifesciences Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Greenwich Lifesciences is a key component of Greenwich Lifesciences valuation and have some predictive power on the future returns of a Greenwich Lifesciences.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Greenwich Lifesciences in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
1.898.4615.03
Details
Intrinsic
Valuation
LowReal ValueHigh
8.0026.0832.65
Details
Naive
Forecast
LowNext ValueHigh
2.799.3615.93
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.798.309.82
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Greenwich Lifesciences. Your research has to be compared to or analyzed against Greenwich Lifesciences' peers to derive any actionable benefits. When done correctly, Greenwich Lifesciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Greenwich Lifesciences.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested over 20 shares
Please check Macroaxis Advice on Greenwich Lifesciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
The data published in Greenwich Lifesciences' official financial statements usually reflect Greenwich Lifesciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Greenwich Lifesciences. For example, before you start analyzing numbers published by Greenwich accountants, it's critical to develop an understanding of what Greenwich Lifesciences' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Greenwich Lifesciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Greenwich Lifesciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Greenwich Lifesciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Greenwich Lifesciences. Please utilize our Beneish M Score to check the likelihood of Greenwich Lifesciences' management to manipulate its earnings.